Diality Names Dr. Chris Springer to Board of Directors

IRVINE, Calif.--(BUSINESS WIRE)--Diality Inc., a medical device company that has developed the Moda-flx Hemodialysis System™, today announced the addition of Dr. Chris Springer to its board of directors.

Dr. Springer brings 30 years of commercial and strategic experience in the pharmaceutical and biotech industries to Diality. As Chief Strategy Officer for Vifor Pharma, he created a joint renal-drug company between Vifor Pharmaceuticals and Fresenius Medical Care as well as oversaw a series of licensing deals and acquisitions, culminating in the acquisition of Vifor Pharma by CSL for $11.7B. Prior to Vifor Pharma, Springer also spent time in executive roles with Amgen. He sits on the board of multiple biotech firms, including Adrenomed, Nagi Bioscience, Quercis Pharma and HICT.

“Chris’s commercial experience and strategic focus is exactly what Diality needs as we transition to the early stages of commercialization of the Moda-flx Hemodialysis System,” said Osman Khawar, MD, CEO of Diality. “His guidance and input into our growth strategy will help reinforce the unique benefit offered to clinicians, providers, and patients by the clinical flexibility and ease of use that the Moda-flx Hemodialysis System brings to the dialysis market.”

The Moda-flx Hemodialysis System is designed to empower kidney care professionals with a wide range of variable flow rates, integrated reverse osmosis water filtration, and an intuitive, easy-to-use graphical user interface. The Moda-flx Hemodialysis System provides clinicians the flexibility to easily customize each hemodialysis experience according to patient needs in one integrated system. The platform’s compact footprint and mobility enable seamless integration and transportation within dialysis care settings.

“This is an incredibly exciting time to join Diality,” added Springer. “Diality is primed for success on many fronts over the next 12-24 months, and I look forward to adding to the existing leadership team to execute the company’s mission of improving lives impacted by kidney disease by successfully bringing the Moda-flx Hemodialysis System to market.”

About Diality

Diality is a medical device company focused on developing solutions to improve lives impacted by kidney disease. The Moda-flx Hemodialysis System is a user-friendly, mobile, and connected hemodialysis platform designed to maximize clinical flexibility by combining prescription capabilities of in-center systems with the ease-of-use of next generation hemodialysis devices. Please visit www.diality.com or find us on LinkedIn to learn more about Diality and The Moda-flx Hemodialysis System™.